{"id":10053,"date":"2026-05-22T05:00:00","date_gmt":"2026-05-22T03:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=971f091e368bd57923b1f84ba6b63b8f"},"modified":"2026-05-22T05:00:00","modified_gmt":"2026-05-22T03:00:00","slug":"embc-shareholder-alert-investors-encouraged-to-contact-kirby-mcinerney-llp-about-potential-securities-laws-violations","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=10053","title":{"rendered":"EMBC SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations"},"content":{"rendered":"

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP<\/a> reminds investors of its investigation on behalf of Embecta Corp. (\u201cEmbecta\u201d or the \u201cCompany\u201d) (NASDAQ:EMBC) investors concerning the Company\u2019s and\/or members of its senior management\u2019s possible violation of the federal securities laws or other unlawful business practices.<\/p><\/a><\/a>

\n[LEARN MORE ABOUT THE INVESTIGATION]<\/a><\/p>

\nWhat Happened?<\/b><\/p>

\nOn May 5, 2026, the Company reported second quarter 2026 earnings, which announced results below analyst expectations and included a reduction to full-year 2026 guidance. The Company stated that the two largest contributors to the results were a \u201closs within our pen needle product category, most of which is concentrated at a single customer\u201d and \u201coverall market volume softness for insulin pens and pen needles in the retail channel.\u201d As a result of this, the Company also announced \u201ca review of our cost structure and organizational footprint.\u201d On this news, the price of Embecta shares declined by $5.35 per share, or approximately 58%, from $9.25 per share on May 4, 2026 to close at $3.90 on May 5, 2026.<\/p>

\nWhat Should I Do?<\/b><\/p>

\nAt this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.<\/p>

\nIf you purchased or otherwise acquired Embecta securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro<\/a> of Kirby McInerney LLP<\/a> by email at investigations@kmllp.com<\/a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.<\/p>

\n[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]<\/a><\/p>

\nKirby McInerney LLP<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website<\/a>.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nKirby McInerney LLP\nLauren Molinaro, Esq.\n212-699-1171\nhttps:\/\/www.kmllp.com<\/a>https:\/\/securitiesleadplaintiff.com\/<\/a>investigations@kmllp.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Embecta Corp. (\u201cEmbecta\u201d or the \u201cCompany\u201d) (NASDAQ:EMBC) investors concerning the Company\u2019s and\/or members of its senior management\u2019s pos…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10053","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10053"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10053\/revisions"}],"predecessor-version":[{"id":10054,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/10053\/revisions\/10054"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}